Neurofilament proteins in axonal regeneration and neurodegenerative diseases

Neural Regeneration Research

Volumn 7, Issue 8, 2012, Pages 620-626

  Wang, Haitao ^a   Wu, Minfei ^a   Zhan, Chuanjun ^a   Ma, Enyuan ^b   Yang, Maoguang ^a   Yang, Xiaoyu ^a   Li, Yingpu ^a  

^a JILIN UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Axonal regeneration; Nerve injury; Neurodegenerative diseases; Neurofilament protein; Post transcriptional regulation; Reviews

Indexed keywords

MESSENGER RNA; NEUROFILAMENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DEGENERATIVE DISEASE; DIABETIC NEUROPATHY; GENE EXPRESSION; GLYCOSYLATION; HUMAN; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROFILAMENT; NONHUMAN; PARKINSON DISEASE; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 84859204903     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.08.010     Document Type: Article

References (86)

1. Valentin G. Über den Verlauf und die letzten Enden der Nerven. Breslau, Gedruckt bei Grass, Barth und Comp. 1836.
2. Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science. 2005;309:1514-1518.
3. Lin AC, Holt CE. Function and regulation of local axonal translation. Curr Opin Neurobiol. 2008;18:60-68.
4. Xiao S, McLean J, Robertson J. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim Biophys Acta. 2006;1762:1001-1012.
5. Liu Y, Gervasi C, Szaro BG. A crucial role for hnRNP K in axon development in Xenopus laevis. Development. 2008;135: 3125-3135.
6. Coulombe PA, Bousquet O, Ma L, et al. The 'ins' and 'outs' of intermediate filament organization. Trends Cell Biol. 2000;10: 420-428.
7. Goldman RD, Grin B, Mendez MG, et al. Intermediate filaments: versatile building blocks of cell structure. Curr Opin Cell Biol. 2008;20:28-34.
8. Helfand BT, Mendez MG, Pugh J, et al. A role for intermediate filaments in determining and maintaining the shape of nerve cells. Mol Biol Cell. 2003;14(12):5069-5081.
9. Hisanaga S, Hirokawa N. Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. Mol Biol. 1988;202(2):297-305.
10. Perrot R, Berges R, Bocquet A, et al. Review of the multiple aspects of neurofilament functions and their possible contribution to neurodegeneration. Mol Neurobiol. 2008;38:27-65.
11. Carter J, Gragerov A, Konvicka K, et al. Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J Biol Chem. 1998;273:5101-5108.
12. Yuan A, Rao MV, Sasaki T, et al. Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J Neurosci. 2006;26(39):10006-10019.
13. Rammensee S, Janmey PA, Bausch AR. Mechanical and structural properties of in vitro neurofilament hydrogels. Eur Biophys J. 2007;36:661-668.
14. Heins S, Wong PC, Muller S, et al. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J Cell Biol. 1993;123:1517-1533.
15. Leterrier JF, Käs J, Hartwig J, et al. Mechanical effects of neurofilament cross-bridges. Modulation by phosphorylation, lipids, and interactions with F-actin. J Biol Chem. 1996;271: 15687-15694.
16. Kreplak L, Bar H, Leterrier JF, et al. Exploring the mechanical behavior of single intermediate filaments. J Mol Biol. 2005;354: 569-577.
17. Chang R, Kwak Y, Gebremichael Y. Structural properties of neurofilament sidearms: sequence-based modeling of neurofilament architecture. J Mol Biol. 2009;391:648-660.
18. Lees JF, Shneidman PS, Skuntz SF, et al. The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J. 1988;7:1947-1955.
19. Thyagarajan A, Strong MJ, Szaro BG. Post-transcriptional control of neurofilaments in development and disease. Exp Cell Res. 2007;313:2088-2097.
20. Zhu Y, Lee HC, Zhang L. An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells. DNA Cell Biol. 2002;21:333-346.
21. Huang F, Dong X, Zhang L, et al. GM1 and nerve growth factor modulate mitochondrial membrane potential and neurofilament light mRNA expression in cultured dorsal root ganglion and spinal cord neurons during excitotoxic glutamate exposure. J Clin Neurosci. 2010;17:495-500.
22. Hoffman PN, Pollock SC, Striph GG. Altered gene expression after optic nerve transection: reduced neurofilament expression as a general response to axonal injury. Exp Neurol. 1993;119: 32-36.
23. Cañete-Soler R, Wu J, Zhai J, et al. p190RhoGEF Binds to a destabilizing element in the 3' untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem. 2001;276:32046-32050.
24. Shokouhi BN, Wong BZ, Siddiqui S, et al. Microglial responses around intrinsic CNS neurons are correlated with axonal regeneration. BMC Neurosci. 2010;11:13.
25. Sihag RK, Inagaki M, Yamaguchi T, et al. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp Cell Res. 2007;313:2098-2109.
26. Lee S, Sunil N, Shea TB. C-terminal neurofilament phosphorylation fosters neurofilament-neurofilament associations that compete with axonal transport. Cytosleleton. 2011;68:8-17.
27. Stevenson W, Chang R, Gebremichael Y. Phosphorylation-mediated conformational changes in the mouse neurofilament architecture: insight from a neurofilament brush model. Mol Biol. 2011;405:1101-1118.
28. Nixon RA, Lewis SE. Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo. J Biol Chem. 1986;261:16298-16301.
29. Sihag RK, Jaffe H, Nixon RA, et al. Serine-23 is a major protein kinase A phosphorylation site on the aminoterminal head domain of the middle molecular mass subunit of neurofilament proteins. J Neurochem. 1999;72:491-499.
30. Wagner OI, Rammensee S, Korde N, et al. Softness, strength and self-repair in intermediate filament networks. Exp Cell Res. 2007; 313:2228-2235.
31. Kushkuley J, Metkar S, Chan WK, et al. Aluminum induces neurofilament aggregation by stabilizing cross-bridging of phosphorylated c-terminal sidearms. Brain Res. 2010;1322: 118-123.
32. Strack S, Westphal RS, Colbran RJ, et al. Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res. 1997;49:15-28.
33. Lobsiger CS, Garcia ML, Ward CM, et al. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. Proc Natl Acad Sci U S A. 2005;102: 10351-10356.
34. Slawson C, Hart GW. Dynamic interplay between OGlcNAc and O-phosphate: the sweet side of protein regulation. Curr Opin Struct Biol. 2003;13:631-636.
35. Ryle C, Leow CK, Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve. 1997;20:577-584.
36. Chou SM, Wang HS, Taniguchi A, et al. Advanced glycation end products in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol Med. 1998;4:324-332.
37. Tashiro T, Imai R, Komiya Y. Early effects of beta, beta'-iminodipropionitrile on tubulin solubility and neurofilament phosphorylation in the axon. J Neurochem. 1994;63:291-300.
38. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 1998;279:519-526.
39. Wagner OI, Ascano J, Tokito M, et al. The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol Biol Cell. 2004;15:5092-5100.
40. Miyasaka H, Okabe S, Ishiguro K, et al. Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. J Biol Chem. 1993;268:22695-22702.
41. Frappier T, Stetzkowski-Marden F, Pradel LA. Interaction domains of neurofilament light chain and brain spectrin. Biochem J. 1991; 275:521-527.
42. Young KG, Kothary R. Dystonin/Bpag1--a link to what? Cell Motil Cytoskeleton. 2007;64:897-905.
43. Hao R, MacDonald RG, Ebadi M, et al. Stable interaction between G-actin and neurofilament light subunit in dopaminergic neurons. Neurochem Int. 1997;31:825-834.
44. Haddad LA, Smith N, Bowser M, et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J Biol Chem. 2002;277:44180-44186.
45. Perkins GA, Sosinsky GE, Ghassemzadeh S, et al. Electron tomographic analysis of cytoskeletal cross-bridges in the paranodal region of the node of Ranvier in peripheral nerves. J Struct Biol. 2008;161:469-480.
46. Loureiro SO, Heimfarth L, Pelaez Pde L, et al. Hyperhomocysteinemia selectively alters expression and stoichiometry of intermediate filament and induces glutamate-and calcium-mediated mechanisms in rat brain during development. Int J Dev Neurosci. 2010;28:21-30.
47. Shah JV, Flanagan LA, Janmey PA, et al. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol Biol Cell. 2000;11:3495-3508.
48. Yabe JT, Jung C, Chan WK, et al. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil Cytoskeleton. 2000;45:249-262.
49. Ackerley S, Grierson AJ, Banner S, et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci. 2004;26:354-364.
50. Nakamura Y, Hashimoto R, Kashiwagi Y, et al. Casein kinase II is responsible for phosphorylation of NF-L at Ser-473. FEBS Lett. 1999;455:83-86.
51. Sharma M, Sharma P, Pant HC. CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells. J Neurochem. 1999;73:79-86.
52. Guidato S, Tsai LH, Woodgett J, et al. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J Neurochem. 1996;66:1698-1706.
53. Kim OJ, Ariano MA, Lazzarini RA, et al. Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization. J Neurosci. 2002;22:5920-5930.
54. Ehlers MD, Fung ET, O'Brien RJ, et al. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci. 1998;18:720-730.
55. Dubey M, Hoda S, Chan WK, et al. Reexpression of vimentin in differentiated neuroblastoma cells enhances elongation of axonal neurites. J Neurosci Res. 2004;78:245-249.
56. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol. 2004;58: 131-148.
57. Undamatla J, Szaro BG. Differential expression and localization of neuronal intermediate filament proteins within newly developing neurites in dissociated cultures of Xenopus laevis embryonic spinal cord. Cell Motil Cytoskeleton. 2001;49:16-32.
58. Uchida A, Tashiro T, Komiya Y, et al. Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons. J Neurochem. 2004;88:735-745.
59. Perrot R, Eyer J. Neuronal intermediate filaments and neurodegenerative disorders. Brain Res Bull. 2009;80:282-295.
60. Willis DE, van Niekerk EA, Sasaki Y, et al. Extracellular stimuli specifically regulate localized levels of individual neuronal mRNAs. J Cell Biol. 2007;178:965-980.
61. Thyagarajan A, Szaro BG. Dynamic endogenous association of neurofilament mRNAs with K-homology domain ribonucleoproteins in developing cerebral cortex. Brain Res. 2008;1189:33-42.
62. Ananthakrishnan L, Gervasi C, Szaro BG. Dynamic regulation of middle neurofilament (NF-M) RNA pools during optic nerve regeneration. Neuroscience. 2008;153:144-153.
63. Ananthakrishnan L, Szaro BG. Transcriptional and translational dynamics of light neurofilament subunit RNAs during Xenopus laevis optic nerve regeneration. Brain Res. 2009;1250:27-40.
64. Vogelaar CF, Gervasi NM, Gumy LF, et al. Axonal mRNAs: characterisation and role in the growth and regeneration of dorsal root ganglion axons and growth cones. Mol Cell Neurosci. 2009; 42:102-115.
65. Volkening K, Leystra-Lantz C, Strong MJ. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF) in humans. Amyotroph Lateral Scler. 2010;11:97-103.
66. Rotshenker S, Tal M. The transneuronal induction of sprouting and synapse formation in intact mouse muscles. J Physiol. 1985;360: 387-396.
67. Rotshenker S, Tal M. The transneuronal induction of sprouting and synapse formation in intact mouse muscles. J Physiol. 1985; 360:387-396.
68. Moskowitz PF, Oblinger MM. Transcriptional and posttranscriptionalmechanisms regulating neurofilament and tubulingene expression during normal development of the rat brain. Mol. Brain Res. 1995;30:211-222.
69. Menzies FM, Grierson AJ, Cookson MR, et al. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J Neurochem. 2002;82: 1118-1128.
70. Strong MJ, Leystra-Lantz C, Ge WW. Intermediate filament steady-state mRNA levels in amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2004;316:317-322.
71. Ge WW, Leystra-Lantz C, Wen W, et al. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J Biol Chem. 2003;278: 26558-26563.
72. Strong MJ, Volkening K, Hammond R, et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci. 2007;35:320-327.
73. Ge WW, Volkening K, Leystra-Lantz C, et al. 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 30UTR. Mol Cell Neurosci. 2007;34:80-87.
74. Ge WW, Wen W, Strong W, et al. Mutant copper/zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem. 2005;280:118-124.
75. McLean JR, Sanelli TR, Leystra-Lantz C, et al. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL(+/+) and NFL(-/-) mice. Glia. 2005;52:59-69.
76. Nie Z, Wu J, Zhai J, et al. Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J Neurosci. 2002;22:7662-7670.
77. Lüdemann N, Clement A, Hans VH, et al. O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J Biol Chem. 2005;280:31648-31658.
78. Abdo WF, Bloem BR, Van Geel WJ, et al. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease. Neurobiol Aging. 2007;28:742-747.
79. Pfister EL, Kennington L, Straubhaar J, et al. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. Curr Biol. 2009;19:774-778.
80. Deng Y, Li B, Liu F, et al. Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J. 2008;22:138-145.
81. Han F, Bulman DE, Panisset M, et al. Neurofilament M gene in a French-Canadian population with Parkinson's disease. Can J Neurol Sci. 2005;32:68-70.
82. Fabrizi GM, Cavallaro T, Angiari C, et al. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain. 2007;130: 394-403.
83. Momeni P, Cairns NJ, Perry RH, et al. Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). Neurobiol Aging. 2006;27:778. e1-778. e6.
84. Zochodne DW, Sun HS, Cheng C, et al. Accelerated diabetic neuropathy in axons without neurofilaments. Brain. 2004;127: 2193-2200.
85. Yang Y, Allen E, Ding J, et al. Giant axonal neuropathy. Cell Mol Life Sci. 2007;64:601-609.
86. Jones LG, Prins J, Park S, et al. Lead exposure during development results in increased neurofilament phosphorylation, neuritic beading, and temporal processing deficits within the murine auditory brainstem. J Comp Neurol. 2008;506:1003-1017.